Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.

Barakat NH, Zheng X, Gilley CB, MacDonald M, Okolotowicz K, Cashman JR, Vyas S, Beck JM, Hadad CM, Zhang J.

Chem Res Toxicol. 2009 Oct;22(10):1669-79. doi: 10.1021/tx900096j.

2.
3.

[Today's threat of use of organophosphorus compounds].

Sokołowski R, Płusa T.

Pol Merkur Lekarski. 2015 Sep;39(231):176-80. Review. Polish.

PMID:
26449583
4.

A review of nerve agent exposure for the critical care physician.

Leikin JB, Thomas RG, Walter FG, Klein R, Meislin HW.

Crit Care Med. 2002 Oct;30(10):2346-54. Review.

PMID:
12394966
5.

Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.

Lockridge O, Norgren RB Jr, Johnson RC, Blake TA.

Chem Res Toxicol. 2016 Sep 19;29(9):1381-92. doi: 10.1021/acs.chemrestox.6b00228. Epub 2016 Aug 31. Review.

6.

Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.

Abou-Donia MB, Siracuse B, Gupta N, Sobel Sokol A.

Crit Rev Toxicol. 2016 Nov;46(10):845-875. Epub 2016 Oct 5. Review.

PMID:
27705071
7.

[Cholinesterases: structure, role, and inhibition].

Bosak A, Katalinić M, Kovarik Z.

Arh Hig Rada Toksikol. 2011 Jun;62(2):175-90. doi: 10.2478/10004-1254-62-2011-2107. Review. Croatian.

PMID:
21705306
8.

[Butyrylcholinesterase: 3D structure, catalytic mechanisms].

Nachon F, Nicolet Y, Masson P.

Ann Pharm Fr. 2005 Jun;63(3):194-206. Review. French.

PMID:
15976688
9.

The role of oxidative stress in organophosphate and nerve agent toxicity.

Pearson JN, Patel M.

Ann N Y Acad Sci. 2016 Aug;1378(1):17-24. doi: 10.1111/nyas.13115. Epub 2016 Jul 2. Review.

10.

Current and emerging strategies for organophosphate decontamination: special focus on hyperstable enzymes.

Jacquet P, Daudé D, Bzdrenga J, Masson P, Elias M, Chabrière E.

Environ Sci Pollut Res Int. 2016 May;23(9):8200-18. doi: 10.1007/s11356-016-6143-1. Epub 2016 Feb 2. Review.

PMID:
26832878
11.

Human butyrylcholinesterase efficacy against nerve agent exposure.

Reed BA, Sabourin CL, Lenz DE.

J Biochem Mol Toxicol. 2017 May;31(5). doi: 10.1002/jbt.21886. Epub 2017 Feb 22. Review.

PMID:
28225154
12.

Review of Acute Human-Toxicity Estimates for Selected Chemical-Warfare Agents.

National Research Council (US) Committee on Toxicology.

Washington (DC): National Academies Press (US); 1997.

13.

The role of genetic background in susceptibility to chemical warfare nerve agents across rodent and non-human primate models.

Matson LM, McCarren HS, Cadieux CL, Cerasoli DM, McDonough JH.

Toxicology. 2018 Jan 15;393:51-61. doi: 10.1016/j.tox.2017.11.003. Epub 2017 Nov 4. Review.

PMID:
29113833
14.

Toxicity, V-Series, Ve, Vg, Vm, Vx.

Smith ME, Swoboda HD.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-.
2017 Jun 12.

Supplemental Content

Support Center